REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 25 filers reported holding REDHILL BIOPHARMA LTD in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,400,000 | +45.5% | 409,086 | -2.8% | 0.09% | +33.8% |
| Q4 2018 | $2,337,000 | -37.1% | 421,000 | 0.0% | 0.07% | -32.7% |
| Q3 2018 | $3,717,000 | +3.5% | 421,000 | 0.0% | 0.10% | -1.0% |
| Q2 2018 | $3,591,000 | +65.6% | 421,000 | 0.0% | 0.10% | +47.8% |
| Q1 2018 | $2,168,000 | +0.2% | 421,000 | 0.0% | 0.07% | -17.9% |
| Q4 2017 | $2,164,000 | -52.5% | 421,000 | 0.0% | 0.08% | -54.6% |
| Q3 2017 | $4,551,000 | +25.4% | 421,000 | 0.0% | 0.18% | +9.5% |
| Q2 2017 | $3,629,000 | -10.1% | 421,000 | 0.0% | 0.17% | -17.6% |
| Q1 2017 | $4,037,000 | -8.3% | 421,000 | 0.0% | 0.20% | -9.3% |
| Q4 2016 | $4,404,000 | +28.9% | 421,000 | +71.1% | 0.23% | +20.2% |
| Q3 2016 | $3,417,000 | +27.8% | 246,000 | 0.0% | 0.19% | +24.5% |
| Q2 2016 | $2,673,000 | -11.3% | 246,000 | 0.0% | 0.15% | -16.1% |
| Q1 2016 | $3,014,000 | -4.9% | 246,000 | 0.0% | 0.18% | -10.9% |
| Q4 2015 | $3,168,000 | -0.3% | 246,000 | 0.0% | 0.20% | -14.8% |
| Q3 2015 | $3,176,000 | – | 246,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 717,203 | $9,962,000 | 0.89% |
| BANK HAPOALIM BM | 147,504 | $2,049,000 | 0.48% |
| MENORA MIVTACHIM HOLDINGS LTD. | 246,000 | $3,417,000 | 0.19% |
| Family Management Corp | 16,500 | $229,000 | 0.13% |
| Orbimed Advisors | 564,900 | $7,846,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 63,800 | $888,000 | 0.03% |
| INGALLS & SNYDER LLC | 41,550 | $577,000 | 0.03% |
| Candriam S.C.A. | 71,267 | $992,000 | 0.02% |
| MONETARY MANAGEMENT GROUP INC | 3,000 | $42,000 | 0.02% |
| D.A. DAVIDSON & CO. | 26,500 | $368,000 | 0.01% |